These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36156593)

  • 1. HIV prevention for the next decade: Appropriate, person-centred, prioritised, effective, combination prevention.
    Godfrey-Faussett P; Frescura L; Abdool Karim Q; Clayton M; Ghys PD;
    PLoS Med; 2022 Sep; 19(9):e1004102. PubMed ID: 36156593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
    Stover J; Glaubius R; Teng Y; Kelly S; Brown T; Hallett TB; Revill P; Bärnighausen T; Phillips AN; Fontaine C; Frescura L; Izazola-Licea JA; Semini I; Godfrey-Faussett P; De Lay PR; Benzaken AS; Ghys PD
    PLoS Med; 2021 Oct; 18(10):e1003831. PubMed ID: 34662333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ending the epidemic of HIV/AIDS by 2030: Will there be an endgame to HIV, or an endemic HIV requiring an integrated health systems response in many countries?
    Assefa Y; Gilks CF
    Int J Infect Dis; 2020 Nov; 100():273-277. PubMed ID: 32920236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact and Cost of the HIV/AIDS National Strategic Plan for Mozambique, 2015-2019--Projections with the Spectrum/Goals Model.
    Korenromp EL; Gobet B; Fazito E; Lara J; Bollinger L; Stover J
    PLoS One; 2015; 10(11):e0142908. PubMed ID: 26565696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening the HIV prevention cascade to maximise epidemiological impact in eastern Zimbabwe: a modelling study.
    Pickles M; Gregson S; Moorhouse L; Dadirai T; Dzamatira F; Mandizvidza P; Maswera R; Museka T; Schaefer R; Skovdal M; Thomas R; Tsenesa B; Mugurungi O; Nyamukapa C; Hallett TB
    Lancet Glob Health; 2023 Jul; 11(7):e1105-e1113. PubMed ID: 37349036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress towards 2020 global HIV impact and treatment targets.
    Mahy MI; Sabin KM; Feizzadeh A; Wanyeki I
    J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25779. PubMed ID: 34546655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving the 95 95 95 targets for all: A pathway to ending AIDS.
    Frescura L; Godfrey-Faussett P; Feizzadeh A A; El-Sadr W; Syarif O; Ghys PD;
    PLoS One; 2022; 17(8):e0272405. PubMed ID: 35925943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast-track interventions for HIV and AIDS epidemic control among key populations: A rapid review.
    Luvuno ZPB; Wiafe E; Mpofana N; Urusla MM; Nxumalo CT
    Afr J Prim Health Care Fam Med; 2024 Apr; 16(1):e1-e12. PubMed ID: 38708735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ending the HIV Epidemic: New York's Quest to Become the First State to Reduce HIV Prevalence.
    Morne JE; Tesoriero JM; Martin EG; Birkhead GS; Holtgrave DR; Hagos K; Zucker H
    Public Health Rep; 2020; 135(1_suppl):65S-74S. PubMed ID: 32735198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global AIDS Reporting-2001 to 2015: Lessons for Monitoring the Sustainable Development Goals.
    Alfvén T; Erkkola T; Ghys PD; Padayachy J; Warner-Smith M; Rugg D; de Lay P
    AIDS Behav; 2017 Jul; 21(Suppl 1):5-14. PubMed ID: 28124296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What will it take to end AIDS in Asia and the Pacific region by 2030?
    Murphy E; Shwe YY; Bhatia R; Bakkali T; Vannakit R
    Sex Health; 2021 Mar; 18(1):41-49. PubMed ID: 33653504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the USA on track to end the HIV epidemic?
    Guilamo-Ramos V; Thimm-Kaiser M; Benzekri A
    Lancet HIV; 2023 Aug; 10(8):e552-e556. PubMed ID: 37541707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus in Cuba: the public health response of a Third World country.
    Santana S; Faas L; Wald K
    Int J Health Serv; 1991; 21(3):511-37. PubMed ID: 1917211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing the Global Fight Against HIV/Aids: Strategies, Barriers, and the Road to Eradication.
    Kumah E; Boakye DS; Boateng R; Agyei E
    Ann Glob Health; 2023; 89(1):83. PubMed ID: 38046536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The struggle against AIDS: between new paradigms and inertia].
    Clumeck N
    Bull Mem Acad R Med Belg; 2010; 165(3-4):173-7; discussion 177-9. PubMed ID: 21171242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV and AIDS: where is the epidemic going?
    Mertens TE; Low-Beer D
    Bull World Health Organ; 1996; 74(2):121-9. PubMed ID: 8706227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ending the HIV epidemic for all, not just some: structural racism as a fundamental but overlooked social-structural determinant of the US HIV epidemic.
    Bowleg L; Malekzadeh AN; Mbaba M; Boone CA
    Curr Opin HIV AIDS; 2022 Mar; 17(2):40-45. PubMed ID: 35102051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Prevention 2020: a framework for delivery and a call for action.
    Dehne KL; Dallabetta G; Wilson D; Garnett GP; Laga M; Benomar E; Fakoya A; Baggaley RC; Nelson LJ; Kasedde S; Bermejo A; Warren M; Benedikt C;
    Lancet HIV; 2016 Jul; 3(7):e323-32. PubMed ID: 27365207
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.